A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor‐Induced Skin Toxicities

BACKGROUND: The efficacy of epidermal growth factor (EGF) receptor (EGFR) inhibitors in patients with non‐small cell lung cancer (NSCLC), pancreatic cancer (PC), or colorectal cancer (CRC) has been demonstrated. However, dermatological reactions to these inhibitors can cause significant physical and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Kim, Young Saing, Ji, Jun Ho, Oh, Sung Yong, Lee, Suee, Huh, Seok Jae, Lee, Ji Hyun, Song, Ki‐Hoon, Son, Choon Hee, Roh, Mee Sook, Lee, Gyeong Won, Lee, Jeeyun, Kim, Seung Tae, Kim, Chan Kyu, Jang, Joung Soon, Hwang, In Gyu, Ahn, Hee Kyung, Park, Lee Chun, Oh, So Yeon, Kim, Seong‐Geun, Lee, Sang‐Cheol, Lim, Do‐Hyoung, Lee, Soon Il, Kang, Jung Hun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2019
Konular:
Symptom Management and Supportive Care
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964120/
https://ncbi.nlm.nih.gov/pubmed/31492766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0221
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller